PPLPHARMA

Piramal Pharma Share Price Piramal Pharma

₹128.9
6.55 (5.35%)
29 March, 2024 12:52 BSE: 543635 NSE: PPLPHARMAISIN: INE0DK501011

Start SIP in Piramal Pharma

Start SIP

Piramal Pharma Performance

Day Range

  • Low 123
  • High 129
₹ 128

52 Week Range

  • Low 62
  • High 149
₹ 128
  • Open Price123
  • Previous Close122
  • Volume5924097

Piramal Pharma Share Price

  • Over 1 Month -1%
  • Over 3 Month -6.7%
  • Over 6 Month 32.14%
  • Over 1 Year 106.41%

Piramal Pharma Key Statistics

P/E Ratio -511.5
PEG Ratio 200.1
Market Cap Cr 17,054
Price to Book Ratio 2.5
EPS 0.5
Dividend 0
Relative Strength Index 54.55
Money Flow Index 52.15
MACD Signal -3.67
Average True Range 4.7
Piramal Pharma Financials
IndicatorDec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 1,0249948461,055
Operating Expenses Qtr Cr 899908830965
Operating Profit Qtr Cr 126861790
Depreciation Qtr Cr 52515053
Interest Qtr Cr 17283434
Tax Qtr Cr 1519-824
Net Profit Qtr Cr 7477-3342
IndicatorMar 2023
Total Revenue Annual Cr 3,784
Operating Expenses Annual Cr 3,346
Operating Profit Annual in Cr 98
Depreciation Cr 192
Interest Annual Cr 116
Tax Annual Cr 54
Net Profit Annual Cr 70
IndicatorMar 2023
Cash from Operating Activity Annual Cr 72
Cash from Investing Activity Annual Cr -435
Cash from Financing Annual Activity Cr 290
Net Cash Flow Annual Cr -73
IndicatorMar 2023
Total ShareHolders Funds Annual Cr 5,262
Fixed Assets Annual Cr 3,018
Total Non Current Assets Annual Cr 5,694
Total Current Assets Annual Cr 2,349
Total Assets Annual Cr 8,042
IndicatorMar 2023
Book Value Per Share Annual Rs 44
ROE Annual % 1
ROCE Annual % 4
Total Debt to Total Equity Annual -
EBDIT Annual Margin % 13
IndicatorDec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 1,9591,9111,7492,164
Operating Expenses Qtr Cr 1,6901,6461,6171,812
Operating Profit Qtr Cr 268266132351
Depreciation Qtr Cr 186185174184
Interest Qtr Cr 106110119104
Tax Qtr Cr 935-945
Net Profit Qtr Cr 105-9950
IndicatorMar 2023
Total Revenue Annual Cr 7,307
Operating Expenses Annual Cr 6,453
Operating Profit Annual in Cr 628
Depreciation Cr 677
Interest Annual Cr 344
Tax Annual Cr 66
Net Profit Annual Cr -186
IndicatorMar 2023
Cash from Operating Activity Annual Cr 484
Cash from Investing Activity Annual Cr -1,339
Cash from Financing Annual Activity Cr 818
Net Cash Flow Annual Cr -37
IndicatorMar 2023
Total ShareHolders Funds Annual Cr 6,774
Fixed Assets Annual Cr 7,780
Total Non Current Assets Annual Cr 9,687
Total Current Assets Annual Cr 4,835
Total Assets Annual Cr 14,523
IndicatorMar 2023
Book Value Per Share Annual Rs 57
ROE Annual % -3
ROCE Annual % 2
Total Debt to Total Equity Annual -
EBDIT Annual Margin % 12

Piramal Pharma Technicals

EMA & SMA

Current Price
₹128.9
6.55 (5.35%)
pointer
  • Bullish Moving Average
  • ___
  • 14
  • Bearish Moving Average
  • ___
  • 2
  • 20 Day
  • ₹124.59
  • 50 Day
  • ₹128.47
  • 100 Day
  • ₹126.12
  • 200 Day
  • ₹119.36
  • 20 Day
  • ₹124.11
  • 50 Day
  • ₹132.45
  • 100 Day
  • ₹130.63
  • 200 Day
  • ₹114.22

Piramal Pharma Resistance and Support

PIVOT
₹127.17
Resistance
First Resistance 131.13
Second Resistance 133.37
Third Resistance 137.33
RSI 54.55
MFI 52.15
MACD Single Line -3.67
MACD -2.80
Support
First Resistance 124.93
Second Resistance 120.97
Third Resistance 118.73

Piramal Pharma Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 6,319,040 248,906,986 39.39
Week 5,986,314 268,426,297 44.84
1 Month 5,152,105 274,298,063 53.24
6 Month 7,466,432 343,754,518 46.04

Piramal Pharma Result Highlights

Piramal Pharma Synopsis

NSE-Medical-Diversified

Piramal Pharma is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 3443.22 Cr. and Equity Capital is Rs. 1193.32 Cr. for the Year ended 31/03/2023. Piramal Pharma Ltd. is a Public Limited Listed company incorporated on 04/03/2020 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is U24297MH2020PLC338592 and registration number is 338592.
Market Cap 17,054
Sales 3,919
Shares in Float 86.00
No of funds 204
Yield
Book Value 2.98
U/D Vol ratio 1
LTDebt / Equity 11
Alpha 0.12
Beta 1.24

Piramal Pharma

Owner NameDec-23Sep-23Aug-23Jun-23
Promoters 35.02%35.02%35.02%34.79%
Mutual Funds 6.28%3.8%3.62%0.91%
Insurance Companies 2.88%3.8%3.82%4.21%
Foreign Portfolio Investors 14.47%14.33%14.18%15.01%
Financial Institutions/ Banks
Individual Investors 15.57%16.95%16.81%16.77%
Others 25.78%26.1%26.55%28.31%

Piramal Pharma Management

Name Designation
Mrs. Nandini Piramal Chairperson
Mr. Peter DeYoung Executive Director
Mr. Vivek Valsaraj Executive Director & CFO
Mr. Neeraj Bharadwaj Non Executive Director
Mr. Nathalie Leitch Non Executive Director
Mr. S Ramadorai Independent Director
Mr. Jairaj Purandare Independent Director
Mr. Peter Stevenson Independent Director
Mr. Sridhar Gorthi Independent Director
Ms. Vibha Paul Rishi Independent Director

Piramal Pharma Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Piramal Pharma Corporate Action

Date Purpose Remarks
2024-01-30 Quarterly Results
2023-10-27 Quarterly Results
2023-08-03 Quarterly Results
2023-05-24 Audited Results
2023-02-08 Quarterly Results & Rights issue

Piramal Pharma FAQs

What is Share Price of Piramal Pharma ?

Piramal Pharma share price is ₹128 As on 29 March, 2024 | 12:38

What is the Market Cap of Piramal Pharma ?

The Market Cap of Piramal Pharma is ₹17053.8 Cr As on 29 March, 2024 | 12:38

What is the P/E ratio of Piramal Pharma ?

The P/E ratio of Piramal Pharma is -511.5 As on 29 March, 2024 | 12:38

What is the PB ratio of Piramal Pharma ?

The PB ratio of Piramal Pharma is 2.5 As on 29 March, 2024 | 12:38

Q2FY23